Cerus Corp (CERS) financials

NASDAQ · Health Care

$2.28 -6.56% Close Oct 30, 2026 Live

Cerus revenue and earnings by year

Cerus's revenue was $234 million in the fiscal year to December 31, 2025, up 16.1% from the year before. Net income was -$15.6 million, -6.7% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 21.9% a year on average.

RevenueNet income
$0$100M$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue23420118718816011494765139
Revenue growth16.1%7.8%-0.8%18.1%39.6%21.8%23.3%48.2%30.7%—
Gross profit140121117113967360442919
Gross margin59.9%59.9%62.5%60.2%60.2%64.0%64.4%58.4%56.1%48.3%
Operating income-9-14-30-34-49-58-66-55-58-61
Operating margin-3.7%-7.1%-16.1%-18.1%-30.7%-51.1%-70.6%-72.3%-112.1%-156.5%
Net income-16-21-37-43-54-60-71-58-61-63
Net margin-6.7%-10.4%-20.1%-22.7%-34.1%-52.4%-76.0%-75.7%-118.0%-160.2%
Diluted EPS-$0.08-$0.11-$0.21-$0.24-$0.31-$0.36-$0.52-$0.44-$0.56-$0.62
Free cash flow19-48-28-35-43-74-32-53-54

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CERS in Markets.

See also: CERS returns

No forecast, no recommendation. This page describes Cerus Corp from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.